The complex relationship between metabolic syndrome and sweeteners

Area of Science:

• Nutrition Science
• Metabolic Health
• Microbiome Research

Background:

• Metabolic syndrome, linked to obesity and sedentary lifestyles, significantly increases type 2 diabetes risk and reduces quality of life.
• Artificial sweeteners are widely used in low-calorie products as sucrose substitutes, with historical assumptions of minimal metabolic interaction.
• Emerging research indicates sweeteners interact with host metabolism and gut microbiota, mediated by sweet-taste receptors.

Purpose of the Study:

• To review the industrial applications of common sweeteners.
• To examine the absorption, distribution, metabolism, gut microbiota metabolism, and excretion of sweeteners.
• To discuss the intricate relationship between metabolic syndrome and sweeteners, referencing in vivo and clinical data.

Main Methods:

• Literature review of industrial sweetener applications.
• Analysis of existing research on sweetener pharmacokinetics and pharmacodynamics.
• Synthesis of data from in vivo and clinical trials concerning sweeteners and metabolic syndrome.

Main Results:

• Sweeteners interact with host metabolism and gut microbiota, challenging previous assumptions.
• Sweet-taste receptors play a key role in mediating sweetener-host interactions.
• The relationship between sweeteners and metabolic syndrome is complex and dose-dependent.

Conclusions:

• Formulating sugar-free products for metabolic syndrome requires careful consideration of sweetener dose, proportions, and individual metabolic factors.
• Understanding sweetener interactions with gut microbiota and sweet-taste receptors is vital for product development.
• Further clinical research, particularly in metabolic syndrome populations, is necessary to elucidate sweetener effects and potential dysbiosis induction.